| 1 | [SID46391420] | Active | | | Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature] | Chain A, Maltoporin Sucrose Complex [gi:3114531] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 46391420 | | CID | 5988 | | Outcome | Active | | BioAssay | Experimentally measured binding affinity data derived from PDB | | AID | 1811 | | BioAssay type | Literature | | Target | Chain A, Maltoporin Sucrose Complex [gi:3114531] | | PubMed | 9299337 | | Data Table |  |
|
| 2 | [SID103557064] | Unspecified | | | Permeability across human Caco-2 cells [AID455986, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Permeability across human Caco-2 cells | | AID | 455986 | | BioAssay type | Literature | | Target | | | PubMed | 19734051 | | Data Table |  |
|
| 3 | [SID103557064] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans [AID588211, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans | | AID | 588211 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 4 | [SID103557064] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents [AID588212, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents | | AID | 588212 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 5 | [SID103557064] | Unspecified | | | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents [AID588213, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents | | AID | 588213 | | BioAssay type | Literature | | Target | | | PubMed | 20014752 | | Data Table |  |
|
| 6 | [SID103557064] | Unspecified | | | Antimicrobial activity against Staphylococcus aureus ATCC 9144 after 24 hrs using thiazoyl blue by agar overlay bioautography method [AID614100, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Staphylococcus aureus ATCC 9144 after 24 hrs using thiazoyl blue by agar overlay bioautography method | | AID | 614100 | | BioAssay type | Literature | | Target | | | PubMed | 21813280 | | Data Table |  |
|
| 7 | [SID103557064] | Unspecified | | | Antimicrobial activity against Bacillus subtilis ATCC 6633 after 24 hrs using thiazoyl blue by agar overlay bioautography method [AID614101, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Bacillus subtilis ATCC 6633 after 24 hrs using thiazoyl blue by agar overlay bioautography method | | AID | 614101 | | BioAssay type | Literature | | Target | | | PubMed | 21813280 | | Data Table |  |
|
| 8 | [SID103557064] | Unspecified | | | Antimicrobial activity against Pseudomonas aeruginosa NCTC 10332 after 24 hrs using thiazoyl blue by agar overlay bioautography method [AID614102, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Pseudomonas aeruginosa NCTC 10332 after 24 hrs using thiazoyl blue by agar overlay bioautography method | | AID | 614102 | | BioAssay type | Literature | | Target | | | PubMed | 21813280 | | Data Table |  |
|
| 9 | [SID103557064] | Unspecified | | | Antimicrobial activity against Candida albicans ATCC 10231 after 24 hrs using thiazoyl blue by agar overlay bioautography method [AID614103, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Candida albicans ATCC 10231 after 24 hrs using thiazoyl blue by agar overlay bioautography method | | AID | 614103 | | BioAssay type | Literature | | Target | | | PubMed | 21813280 | | Data Table |  |
|
| 10 | [SID103557064] | Unspecified | | | Antimicrobial activity against Escherichia coli ATCC 11229 after 24 hrs using thiazoyl blue by agar overlay bioautography method [AID614104, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Antimicrobial activity against Escherichia coli ATCC 11229 after 24 hrs using thiazoyl blue by agar overlay bioautography method | | AID | 614104 | | BioAssay type | Literature | | Target | | | PubMed | 21813280 | | Data Table |  |
|
| 11 | [SID144205646] | Unspecified | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 144205646 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID103557064] | Unspecified | | | Partition coefficient (logP) [AID23672, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) | | AID | 23672 | | BioAssay type | Literature | | Target | | | PubMed | 7381857 | | Data Table |  |
|
| 13 | [SID103557064] | Unspecified | | | Time for the sweetness intensity to decline to half maximal [AID24032, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Time for the sweetness intensity to decline to half maximal | | AID | 24032 | | BioAssay type | Literature | | Target | | | PubMed | 2342061 | | Data Table |  |
|
| 14 | [SID103557064] | Unspecified | | | Partition coefficient (logP) [AID26811, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) | | AID | 26811 | | BioAssay type | Literature | | Target | | | PubMed | 7392035 | | Data Table |  |
|
| 15 | [SID103557064] | Unspecified | | | Ability to bind to guinea pig atrial homogenate [AID78477, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Ability to bind to guinea pig atrial homogenate | | AID | 78477 | | BioAssay type | Literature | | Target | | | PubMed | 7381857 | | Data Table |  |
|
| 16 | [SID103557064] | Unspecified | | | Sensory evaluation was done for sweetness at a concentration of 100000 p.p.m. against sample intensity relative to 10% sucrose. [AID89762, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Sensory evaluation was done for sweetness at a concentration of 100000 p.p.m. against sample intensity relative to 10% sucrose. | | AID | 89762 | | BioAssay type | Literature | | Target | | | PubMed | 3965718 | | Data Table |  |
|
| 17 | [SID103557064] | Unspecified | | | Sensory evaluation was done for sweetness at a concentration of 100000 p.p.m. against compound potency calculated on a molar basis . [AID90086, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Sensory evaluation was done for sweetness at a concentration of 100000 p.p.m. against compound potency calculated on a molar basis . | | AID | 90086 | | BioAssay type | Literature | | Target | | | PubMed | 3965718 | | Data Table |  |
|
| 18 | [SID103557064] | Unspecified | | | Sensory evaluation was done for sweetness at a concentration of 100000 p.p.m. against compound potency calculated on weight basis. [AID90224, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Sensory evaluation was done for sweetness at a concentration of 100000 p.p.m. against compound potency calculated on weight basis. | | AID | 90224 | | BioAssay type | Literature | | Target | | | PubMed | 3965718 | | Data Table |  |
|
| 19 | [SID103557064] | Unspecified | | | Sensory evaluation was done at a concentration of 100000 p.p.m. against other properties. [AID90258, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Sensory evaluation was done at a concentration of 100000 p.p.m. against other properties. | | AID | 90258 | | BioAssay type | Literature | | Target | | | PubMed | 3965718 | | Data Table |  |
|
| 20 | [SID103557064] | Unspecified | | | Sensory evaluation was done at a concentration of 100000 p.p.m. against property of bitterness. [AID90259, Type: Literature] | |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Sensory evaluation was done at a concentration of 100000 p.p.m. against property of bitterness. | | AID | 90259 | | BioAssay type | Literature | | Target | | | PubMed | 3965718 | | Data Table |  |
|
| 21 | [SID103557064] | Unspecified | | | Sensory evaluation was done at a concentration of 100000 p.p.m. against property of sweetness. [AID90260, Type: Literature] | |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Sensory evaluation was done at a concentration of 100000 p.p.m. against property of sweetness. | | AID | 90260 | | BioAssay type | Literature | | Target | | | PubMed | 3965718 | | Data Table |  |
|
| 22 | [SID103557064] | Unspecified | | | Ability to bind to human serum albumin (HSA) [AID91480, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Ability to bind to human serum albumin (HSA) | | AID | 91480 | | BioAssay type | Literature | | Target | | | PubMed | 7381857 | | Data Table |  |
|
| 23 | [SID103557064] | Unspecified | | | The capillary permeability of radioligand was measured in Rat brain [AID189629, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | The capillary permeability of radioligand was measured in Rat brain | | AID | 189629 | | BioAssay type | Literature | | Target | | | PubMed | 7392035 | | Data Table |  |
|
| 24 | [SID103557064] | Unspecified | | | Permeability coefficient in human skin [AID311367, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Permeability coefficient in human skin | | AID | 311367 | | BioAssay type | Literature | | Target | | | PubMed | 17827020 | | Data Table |  |
|
| 25 | [SID103557064] | Unspecified | | | Antibacterial activity against Bacillus subtilis ATCC 6633 after 48 hrs by silica gel plate-based INT-formazan method [AID337692, Type: other] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Antibacterial activity against Bacillus subtilis ATCC 6633 after 48 hrs by silica gel plate-based INT-formazan method | | AID | 337692 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID103557064] | Unspecified | | | Antibacterial activity against Escherichia coli ATCC 25922 after 48 hrs by silica gel plate-based INT-formazan method [AID337693, Type: other] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Antibacterial activity against Escherichia coli ATCC 25922 after 48 hrs by silica gel plate-based INT-formazan method | | AID | 337693 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID103557064] | Unspecified | | | Biodistribution in perfused wild type FVB Mdr1a/Mdr1b positive mouse choroid plexus assessed as tritiated drug level after 2.5 mins relative to control [AID369769, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in perfused wild type FVB Mdr1a/Mdr1b positive mouse choroid plexus assessed as tritiated drug level after 2.5 mins relative to control | | AID | 369769 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 28 | [SID103557064] | Unspecified | | | Biodistribution in BALB/c mouse thalamus assessed as tritiated drug level at 150 uM perfusion after 10 mins by capillary depletion assay in presence of phenylarsine ocide [AID369774, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in BALB/c mouse thalamus assessed as tritiated drug level at 150 uM perfusion after 10 mins by capillary depletion assay in presence of phenylarsine ocide | | AID | 369774 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 29 | [SID103557064] | Unspecified | | | Drug uptake in BALB/c mouse assessed as tritiated drug level at 5 ml/min perfusion after 10 min relative to [14C]sucrose [AID369781, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Drug uptake in BALB/c mouse assessed as tritiated drug level at 5 ml/min perfusion after 10 min relative to [14C]sucrose | | AID | 369781 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 30 | [SID103557064] | Unspecified | | | Biodistribution in wild type FVB Mdr1a/Mdr1b positive mouse caudate putamen assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay [AID369782, Type: Literature] | |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in wild type FVB Mdr1a/Mdr1b positive mouse caudate putamen assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay | | AID | 369782 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 31 | [SID103557064] | Unspecified | | | Biodistribution in wild type FVB Mdr1a/Mdr1b positive mouse hypothalamus assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay [AID369783, Type: Literature] | |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in wild type FVB Mdr1a/Mdr1b positive mouse hypothalamus assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay | | AID | 369783 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 32 | [SID103557064] | Unspecified | | | Biodistribution in wild type FVB Mdr1a/Mdr1b positive mouse brain 4th ventricle choroid plexus assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay [AID369784, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in wild type FVB Mdr1a/Mdr1b positive mouse brain 4th ventricle choroid plexus assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay | | AID | 369784 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 33 | [SID103557064] | Unspecified | | | Biodistribution in wild type FVB Mdr1a/Mdr1b positive mouse pineal gland assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay [AID369785, Type: Literature] | |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in wild type FVB Mdr1a/Mdr1b positive mouse pineal gland assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay | | AID | 369785 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 34 | [SID103557064] | Unspecified | | | Biodistribution in wild type FVB Mdr1a/Mdr1b positive mouse pituitary gland assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay [AID369786, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in wild type FVB Mdr1a/Mdr1b positive mouse pituitary gland assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay | | AID | 369786 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 35 | [SID103557064] | Unspecified | | | Biodistribution in FVB Mdr1a/Mdr1b deficient mouse frontal cortex assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay [AID369787, Type: Literature] | |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in FVB Mdr1a/Mdr1b deficient mouse frontal cortex assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay | | AID | 369787 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 36 | [SID103557064] | Unspecified | | | Biodistribution in FVB Mdr1a/Mdr1b deficient mouse caudate putamen assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay [AID369788, Type: Literature] | |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in FVB Mdr1a/Mdr1b deficient mouse caudate putamen assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay | | AID | 369788 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 37 | [SID103557064] | Unspecified | | | Biodistribution in FVB Mdr1a/Mdr1b deficient mouse hypothalamus assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay [AID369789, Type: Literature] | |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in FVB Mdr1a/Mdr1b deficient mouse hypothalamus assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay | | AID | 369789 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 38 | [SID103557064] | Unspecified | | | Biodistribution in FVB Mdr1a/Mdr1b deficient mouse thalamus assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay [AID369790, Type: Literature] | |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in FVB Mdr1a/Mdr1b deficient mouse thalamus assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay | | AID | 369790 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 39 | [SID103557064] | Unspecified | | | Biodistribution in FVB Mdr1a/Mdr1b deficient mouse cerebellum assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay [AID369791, Type: Literature] | |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in FVB Mdr1a/Mdr1b deficient mouse cerebellum assessed as tritiated drug level at 150 uM perfusion after 30 mins by capillary depletion assay | | AID | 369791 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 40 | [SID103557064] | Unspecified | | | Biodistribution in perfused FVB Mdr1a/Mdr1b deficient mouse choroid plexus assessed as tritiated drug level after 2.5 mins relative to control [AID369793, Type: Literature] | |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in perfused FVB Mdr1a/Mdr1b deficient mouse choroid plexus assessed as tritiated drug level after 2.5 mins relative to control | | AID | 369793 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 41 | [SID103557064] | Unspecified | | | Biodistribution in perfused wild type FVB Mdr1a/Mdr1b positive mouse choroid plexus assessed as tritiated drug level after 30 mins relative to control [AID369795, Type: Literature] | |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in perfused wild type FVB Mdr1a/Mdr1b positive mouse choroid plexus assessed as tritiated drug level after 30 mins relative to control | | AID | 369795 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 42 | [SID103557064] | Unspecified | | | Biodistribution in perfused FVB Mdr1a/Mdr1b deficient mouse choroid plexus assessed as tritiated drug level after 30 mins relative to control [AID369797, Type: Literature] | |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in perfused FVB Mdr1a/Mdr1b deficient mouse choroid plexus assessed as tritiated drug level after 30 mins relative to control | | AID | 369797 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 43 | [SID103557064] | Unspecified | | | Biodistribution in perfused BALB/c mouse choroid plexus assessed as tritiated drug level after 2.5 mins in presence of DMSO relative to control [AID369799, Type: Literature] | |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in perfused BALB/c mouse choroid plexus assessed as tritiated drug level after 2.5 mins in presence of DMSO relative to control | | AID | 369799 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 44 | [SID103557064] | Unspecified | | | Biodistribution in perfused BALB/c mouse choroid plexus assessed as tritiated drug level after 2.5 mins in presence of phenylarsine oxide relative to control [AID369800, Type: Literature] | |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Biodistribution in perfused BALB/c mouse choroid plexus assessed as tritiated drug level after 2.5 mins in presence of phenylarsine oxide relative to control | | AID | 369800 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 45 | [SID103557064] | Unspecified | | | Partition coefficient, log D of the compound [AID369805, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103557064 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | Partition coefficient, log D of the compound | | AID | 369805 | | BioAssay type | Literature | | Target | | | PubMed | 17576845 | | Data Table |  |
|
| 46 | [SID26757665] | Unspecified | | | qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26757665 | | CID | 5988 | | Outcome | Unspecified | | BioAssay | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | | AID | 504749 | | BioAssay type | Literature | | Target | | | PubMed | 21817045 | | Data Table |  |
|
| 47 | [SID26757665] | Inactive | Potency | 0.0405 | S16 Schwann cell PMP22 intronic element firefly luciferase assay [AID624032, Type: confirmatory] | Pmp22 gene product [Rattus norvegicus] [gi:8393992] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26757665 | | CID | 5988 | | Outcome | Inactive | | Potency | 0.0405 [uM] | | BioAssay | S16 Schwann cell PMP22 intronic element firefly luciferase assay | | AID | 624032 | | BioAssay type | confirmatory | | Target | Pmp22 gene product [Rattus norvegicus] [gi:8393992] | | PubMed | | | Data Table |  |
|
| 48 | [SID26757665] | Inactive | Potency | | S16 Schwann cell PMP22 intronic element beta-lactamase assay [AID624044, Type: confirmatory] | Pmp22 gene product [Rattus norvegicus] [gi:8393992] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26757665 | | CID | 5988 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | S16 Schwann cell PMP22 intronic element beta-lactamase assay | | AID | 624044 | | BioAssay type | confirmatory | | Target | Pmp22 gene product [Rattus norvegicus] [gi:8393992] | | PubMed | | | Data Table |  |
|
| 49 | [SID26757665] | Inactive | Potency | | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26757665 | | CID | 5988 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 50 | [SID26757665] | Inactive | Potency | | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26757665 | | CID | 5988 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|